(Q36709162)

15 August 2017

1 reference

title

Formulation considerations of intranasal corticosteroids for the treatment of allergic rhinitis (English)

1 reference

15 August 2017

1

Eli O Meltzer

1 reference

15 August 2017

publication date

1 January 2007

1 reference

Annals of Allergy, Asthma & Immunology

15 August 2017

published in

1 reference

15 August 2017

volume

98

1 reference

15 August 2017

issue

1

1 reference

15 August 2017

page(s)

12-21

1 reference

Allergic rhinitis: definition, epidemiology, pathophysiology, detection, and diagnosis

15 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960854-X

7 January 2021

Economic impact and quality-of-life burden of allergic rhinitis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960854-X

7 January 2021

Quality of life in adults and children with allergic rhinitis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960854-X

7 January 2021

Adverse effects of medications for rhinitis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960854-X

7 January 2021

Allergic rhinitis and its impact on asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960854-X

7 January 2021

Nasal congestion secondary to allergic rhinitis as a cause of sleep disturbance and daytime fatigue and the response to topical nasal corticosteroids

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960854-X

7 January 2021

Intranasal corticosteroids for allergic rhinitis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960854-X

7 January 2021

Contact urticaria to a corticosteroid cream: polysorbate 60

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960854-X

7 January 2021

Polysorbate 80 hypersensitivity

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960854-X

7 January 2021

Contact allergy to Tween 80 in an inhalation suspension

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960854-X

7 January 2021

An allergic reaction to erythropoietin secondary to polysorbate hypersensitivity

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960854-X

7 January 2021

Strong irritants masquerading as skin allergens: the case of benzalkonium chloride

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960854-X

7 January 2021

The effects of topical nasal steroids on rat respiratory mucosa in vivo, with special reference to benzalkonium chloride

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960854-X

7 January 2021

The effect of benzalkonium chloride on rabbit nasal mucosa in vivo: an electron microscopy study

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960854-X

7 January 2021

Effects of Topical Nasal Steroids on Human Respiratory Mucosa and Human Granulocytes in Vitro

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960854-X

7 January 2021

The effect of decongestive nosedrops on human respiratory mucosa in Vitro

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960854-X

7 January 2021

Is the use of benzalkonium chloride as a preservative for nasal formulations a safety concern? A cautionary note based on compromised mucociliary transport

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960854-X

7 January 2021

Benzalkonium chloride as a preservative in nasal solutions: re-examining the data

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960854-X

7 January 2021

Safety review of benzalkonium chloride used as a preservative in intranasal solutions: an overview of conflicting data and opinions

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960854-X

7 January 2021

Effect of topical nasal steroid sprays on nasal mucosa and ciliary function

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960854-X

7 January 2021

Influence of preservatives and topical steroids on ciliary beat frequency in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960854-X

7 January 2021

Effect of betamethasone and betamethasone with neomycin nasal drops on human nasal mucociliary clearance and ciliary beat frequency

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960854-X

7 January 2021

Immediate and short-term effects of benzalkonium chloride on the human nasal mucosa in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960854-X

7 January 2021

The lack of effect of benzalkonium chloride on the cilia of the nasal mucosa in patients with perennial allergic rhinitis: a combined functional, light, scanning and transmission electron microscopy study

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960854-X

7 January 2021

A comparison of nasal clearance after treatment of perennial allergic rhinitis with budesonide and mometasone

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960854-X

7 January 2021

Ten days' use of oxymetazoline nasal spray with or without benzalkonium chloride in patients with vasomotor rhinitis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960854-X

7 January 2021

Benzalkonium chloride in a decongestant nasal spray aggravates rhinitis medicamentosa in healthy volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960854-X

7 January 2021

Effect on the nasal mucosa of long-term treatment with oxymetazoline, benzalkonium chloride, and placebo nasal sprays

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960854-X

7 January 2021

Benzalkonium chloride in nasal decongestive sprays has a long-lasting adverse effect on the nasal mucosa of healthy volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960854-X

7 January 2021

Long-term use of preservatives on rat nasal respiratory mucosa: effects of benzalkonium chloride and potassium sorbate

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960854-X

7 January 2021

Effects of preservatives in nasal formulations on the mucosal integrity: an electron microscopic study

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960854-X

7 January 2021

Safety-assessment of 3-methoxyquercetin as an antirhinoviral compound for nasal application: effect on ciliary beat frequency

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960854-X

7 January 2021

Pharmacological effects of formulation vehicles : implications for cancer chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960854-X

7 January 2021

Beneficial effects of propylene and polyethylene glycol and saline in the treatment of perennial rhinitis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960854-X

7 January 2021

Subchronic nose-only inhalation study of propylene glycol in Sprague-Dawley rats

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960854-X

7 January 2021

"Inactive" Ingredients in Pharmaceutical Products: Update (Subject Review)

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960854-X

7 January 2021

Contact allergy to corticosteroids in patients using inhaled or intranasal corticosteroids for allergic rhinitis or asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960854-X

7 January 2021

In vitro effect of beclomethasone dipropionate and flunisolide on the mobility of human nasal cilia

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960854-X

7 January 2021

Rheological behavior of nasal sprays in shear and extension

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960854-X

7 January 2021

Intranasal steroid sprays in the treatment of rhinitis: is one better than another?

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960854-X

7 January 2021

Patient preferences for sensory attributes of intranasal corticosteroids and willingness to adhere to prescribed therapy for allergic rhinitis: a conjoint analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960854-X

7 January 2021

Two multicenter, randomized, single-blind, single-dose, crossover studies of specific sensory attributes of budesonide aqueous nasal spray and fluticasone propionate nasal spray

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960854-X

7 January 2021

A comparison of the efficacy and patient acceptability of budesonide and beclomethasone dipropionate aqueous nasal sprays in patients with perennial rhinitis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960854-X

7 January 2021

Patient preferences and sensory comparisons of three intranasal corticosteroids for the treatment of allergic rhinitis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960854-X

7 January 2021

Development of questionnaires to measure patient preferences for intranasal corticosteroids in patients with allergic rhinitis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960854-X

7 January 2021

A preference evaluation study comparing the sensory attributes of mometasone furoate and fluticasone propionate nasal sprays by patients with allergic rhinitis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960854-X

7 January 2021

Regional deposition of nebulized hypodense nonisotonic solutions in the human respiratory tract

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960854-X

7 January 2021

Comparison of hypotonic and isotonic solutions containing sodium hyaluronate on the symptomatic treatment of dry eye patients

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960854-X

7 January 2021

Physiologic and hypertonic saline solutions impair ciliary activity in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960854-X

7 January 2021

Hypertonic saline decreases ciliary movement in human nasal epithelium in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960854-X

7 January 2021

Brain delivery of vasoactive intestinal peptide (VIP) following nasal administration to rats.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960854-X

7 January 2021

Nasal insulin delivery in the chitosan solution: in vitro and in vivo studies.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960854-X

7 January 2021

Effects of dose, pH and osmolarity on intranasal absorption of recombinant human erythropoietin in rats

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960854-X

7 January 2021

In situ nasal absorption of midazolam in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960854-X

7 January 2021

Water and electrolyte absorption from hypotonic oral rehydration solution in rat small intestine and colon

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960854-X

7 January 2021

Osmolality and solute concentration--their relationship with oral hydration solution effectiveness: an experimental assessment

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960854-X

7 January 2021

Pharmacokinetics of intranasal corticosteroids

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960854-X

7 January 2021

A comparison of the regional deposition in a model nose of a drug discharged from metered aerosol and metered-pump nasal delivery systems

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960854-X

7 January 2021

The nasal distribution of metered dose inhalers

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960854-X

7 January 2021

Budesonide aqueous nasal spray and pressurized metered dose inhaler in the treatment of adult patients with seasonal allergic rhinitis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960854-X

7 January 2021

A single blind clinical comparison between 2 preparations of budesonide in the treatment of seasonal allergic rhinitis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960854-X

7 January 2021

Treatment of nasal polyposis and chronic rhinosinusitis with fluticasone propionate nasal drops reduces need for sinus surgery

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960854-X

7 January 2021

10.1016/S1081-1206(10)60854-X

Identifiers

DOI

1 reference

release_otcrihrmbjcszitzpbqybannfe

15 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/otcrihrmbjcszitzpbqybannfe

24 November 2022

mapped directly with Wikidata item

1 reference